Everything you need to know about the record CSL dividend

CSL's latest dividend is its biggest yet…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a bouncy but positive day for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares this Tuesday. After starting the week off on a strong footing yesterday, the ASX 200 is continuing that momentum today, with the index currently up 0.05%. But let's talk about what's happening with CSL Ltd (ASX: CSL) shares.

CSL shares are not faring as well as the broader market, to put it nicely. In fact, the ASX 200 healthcare giant is having an awful day.

Yesterday, the CSL share price closed at $308.93. But this morning, those same shares opened at just $300.03 and are currently trading at $296.37. That's down a hefty 4.07% for the day thus far.

It seems investors are not too impressed with the full-year earnings report that the company dropped this morning.

As we covered at the time, these earnings contained some fairly impressive figures. CSL reported an 11% bump in revenues for the 12 months to 30 June to US$14.8 billion.

That helped push the company's net profit after tax before amortisation (NPATA) up by 11% to US$2.91 billion, or up 15% to US$3.01 billion in constant currency terms.

As my Fool colleague covered after market open, it seems that investors may have been disappointed by CSL's guidance for FY2025. The company is expecting to record revenue growth of between 5-7% for the 12 months to 30 June 2025, and an NPATA of between US$3.2 and US$3.3 billion.

But let's talk about the supersized dividend that CSL has just revealed.

Man holding out Australian dollar notes, symbolising dividends.

Image source: Getty Images

CSL ups its dividend to new record high

This morning, CSL revealed that its final dividend for FY2024 would come in at US$1.45 per share. That's a healthy 12.4% rise over the final dividend of US$1.29 ($2.01) per share that investors received last year, as well as a 21.85% increase over April's interim dividend of US$1.19 ($1.80) per share.

We don't yet know whether this latest payment will be in Australian dollars, but at today's exchange rates, US$1.45 would equate to approximately $2.20 per share. Like April's interim dividend, it will not come with any franking credits attached.

Nevertheless, this is a big deal for CSL, as this latest dividend represents a record-high shareholder payout for the company.

However, shareholders will have to wait a while until this passive income arrives in their bank accounts. CSL has scheduled Monday, 9 September next month as this payment's ex-dividend date. So anyone wishing to bag this payout will have to own CSL shares by market close on Friday, 6 September.

The payment date will then roll around on 2 October.

CSL's dividend reinvestment plan (DRP) is not operating for this payment, so shareholders have no other option than to receive a traditional cash payment.

At today's pricing, CSL shares have a trailing dividend yield of 1.28%. If we factor in the newly announced dividend, CSL would have a forward dividend yield of 1.35%.

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Up 1,173% in a year, what do 4DMedical shares have over other healthcare stocks?

Expert explains why 4DMedical is somewhat sheltered from today's sector headwinds.

Read more »

A couple sits on the bed in their hotel room wearing white robes, both have seen the bad news on their phones.
Earnings Results

What's going on with ResMed shares today?

The sleep disorder treatment company has released its third-quarter update this morning.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Healthcare Shares

Resmed reports double-digit revenue and profit increases in Q3 FY26

Resmed posted double-digit revenue and profit growth in Q3 FY26, with management confident about continued momentum.

Read more »

a woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear shares crashed in April, but is a comeback looming?

This ASX 200 healthcare stock is caught between short-term pain and long-term potential.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder, as if giving comfort.
Healthcare Shares

What's making healthcare the worst sector on the ASX 200, down 39% in a year?

An expert outlines the key headwinds weighing on the industry and share prices today.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

Good news, falling shares: What's dragging this ASX stock lower?

In biotech, strong updates don't always push the share price higher.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Healthcare Shares

Mesoblast shares: Cash burn falls and Ryoncil® sales climb

Mesoblast reports higher Ryoncil® sales, improved cash management, and research milestones for the March 2026 quarter.

Read more »